Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease

Molecular Vision

Volumn 22, Issue , 2016, Pages 658-673

  Uribe, Mary Luz ^a,b   Haro, Carmen ^a   Ventero, María Paz ^a,d   Campello, Laura ^a   Cruces, Jesús ^b,c   Martín Nieto, José ^a,b  

^a UNIVERSITY OF ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLGLUCOSAMINYLTRANSFERASE; POMGNT1 PROTEIN; POMT1 PROTEIN; POMT2 PROTEIN; UNCLASSIFIED DRUG; MANNOSYLTRANSFERASE; MESSENGER RNA; PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN O-MANNOSYLTRANSFERASE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; MOUSE; MUSCLE EYE BRAIN DISEASE; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR INNER SEGMENT; POMGNT1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA; YOUNG ADULT; ANIMAL; BOVINE; C57BL MOUSE; CELL LINE; CONFOCAL MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VERTEBRATE PHOTORECEPTOR CELL; WALKER WARBURG SYNDROME;

ANIMALS; CATTLE; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MANNOSYLTRANSFERASES; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHOTORECEPTOR CELLS, VERTEBRATE; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WALKER-WARBURG SYNDROME;

EID: 84976640990     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Breloy I, Pacharra S, Aust C, Hanisch F-G. A sensitive gel-based global O-glycomics approach reveals high levels of mannosyl glycans in the high mass region of the mouse brain proteome. Biol Chem 2012; 393:709-17. [PMID: 22944674].
2. Muntoni F, Brockington M, Torelli S, Brown SC. Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol 2004; 17:205-9. [PMID: 15021250].
3. Hewitt JE. Abnormal glycosylation of dystroglycan in human genetic disease. Biochim Biophys Acta 2009; 1792:853-61. [PMID: 19539754].
4. Dobson CM, Hempel SJ, Stalnaker SH, Stuart R, Wells L. O-Mannosylation and human disease. Cell Mol Life Sci 2013; 70:2849-57. [PMID: 23115008].
5. Martin PT. Congenital muscular dystrophies involving the O-mannose pathway. Curr Mol Med 2007; 7:417-25. [PMID: 17584082].
6. Wells L. The O-mannosylation pathway: Glycosyltransferases and proteins implicated in congenital muscular dystrophy. J Biol Chem 2013; 288:6930-5. [PMID: 23329833].
7. Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 2011; 21:278-85. [PMID: 21397493].
8. Bouchet-Séraphin C, Vuillaumier-Barrot S, Seta N. Dystroglycanopathies: About numerous genes involved in glycosylation of one single glycoprotein. J Neuromuscul Dis 2015; 2:27-38.
9. Endo T. Glycobiology of α-dystroglycan and muscular dystrophy. J Biochem 2015; 157:1-12. [PMID: 25381372].
10. Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 2006; 119:199-207. [PMID: 16410545].
11. Yoshida-Moriguchi T, Campbell KP. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology 2015; 25:702-13. [PMID: 25882296].
12. Samwald M. Dystroglycan in the nervous system. Nat Preced 2007;
13. Sato S, Omori Y, Katoh K, Kondo M, Kanagawa M, Miyata K, Funabiki K, Koyasu T, Kajimura N, Miyoshi T, Sawai H, Kobayashi K, Tani A, Toda T, Usukura J, Tano Y, Fujikado T, Furukawa T. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci 2008; 11:923-31. [PMID: 18641643].
14. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, Herrmann R, Straub V, Talim B, Voit T, Topaloglu H, Toda T, Endo T. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1:717-24. [PMID: 11709191].
15. Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M, Straub V, Bushby K, Manzur A, Talim B, Cowan F, Quinlivan R, Klein A, Longman C, McWilliam R, Topaloglu H, Mein R, Abbs S, North K, Barkovich AJ, Rutherford M, Muntoni F. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008; 64:573-82. [PMID: 19067344].
16. Mercuri E, Messina S, Bruno C, Mora M, Pegoraro E, Comi GP, D’Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P, Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I, Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C, Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S, Scuderi C, Tessa A, Toscano A, Tortorella G, Trevisan CP, Uggetti C, Vasco G, Santorelli FM, Bertini E. Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population study. Neurology 2009; 72:1802-9. [PMID: 19299310].
17. Hehr U, Uyanik G, Gross C, Walter MC, Bohring A, Cohen M, Oehl-Jaschkowitz B, Bird LM, Shamdeen GM, Bogdahn U, Schuierer G, Topaloglu H, Aigner L, Lochmüller H, Winkler J. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease. Neurogenetics 2007; 8:279-88. [PMID: 17906881].
18. Bouchet C, Gonzales M, Vuillaumier-Barrot S, Devisme L, Lebizec C, Alanio E, Bazin A, Bessières-Grattagliano B, Bigi N, Blanchet P, Bonneau D, Bonnières M, Carles D, Delahaye S, Fallet-Bianco C, Figarella-Branger D, Gaillard D, Gasser B, Guimiot F, Joubert M, Laurent N, Liprandi A, Loget P, Marcorelles P, Martinovic J, Menez F, Patrier S, Pelluard-Nehmé F, Perez MJ, Rouleau-Dubois C, Triau S, Laquerrière A, Encha-Razavi F, Seta N. Molecular heterogeneity in fetal forms of type II lissencephaly. Hum Mutat 2007; 28:1020-7. [PMID: 17559086].
19. Clement EM, Godfrey C, Tan J, Brockington M, Torelli S, Feng L, Brown SC, Jimenez-Mallebrera C, Sewry CA, Longman C, Mein R, Abbs S, Vajsar J, Schachter H, Muntoni F. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol 2008; 65:137-41. [PMID: 18195152].
20. Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res 2014; 42:490-5. [PMID: 24270786].
21. Raducu M, Baets J, Fano O, Van Coster R, Cruces J. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O. Eur J Hum Genet 2012; 20:945-52. [PMID: 22419172].
22. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T. Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA 2004; 101:500-5. [PMID: 14699049].
23. Akasaka-Manya K, Manya H, Nakajima A, Kawakita M, Endo T. Physical and functional association of human protein O-mannosyltransferases 1 and 2. J Biol Chem 2006; 281:19339-45. [PMID: 16698797].
24. Takahashi S, Sasaki T, Manya H, Chiba Y, Yoshida A, Mizuno M, Ishida H-K, Ito F, Inazu T, Kotani N, Takasaki S, Takeuchi M, Endo T. A new β-1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 2001; 11:37-45. [PMID: 11181560].
25. Xiong H, Kobayashi K, Tachikawa M, Manya H, Takeda S, Chiyonobu T, Fujikake N, Wang F, Nishimoto A, Morris GE, Nagai Y, Kanagawa M, Endo T, Toda T. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of α-dystroglycan. Biochem Biophys Res Commun 2006; 350:935-41. [PMID: 17034757].
26. Tachikawa M, Kanagawa M, Yu C-C, Kobayashi K, Toda T. Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration. J Biol Chem 2012; 287:8398-406. [PMID: 22275357].
27. Pereira NA, Pu HX, Goh H, Song Z. Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1. J Biol Chem 2014; 289:14762-70. [PMID: 24733390].
28. Liu J, Ball SL, Yang Y, Mei P, Zhang L, Shi H, Kaminski HJ, Lemmon VP, Hu H. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech Dev 2006; 123:228-40. [PMID: 16458488].
29. Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, Endo T, Takeda S. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech Dev 2009; 126:107-16. [PMID: 19114101].
30. Hu H, Candiello J, Zhang P, Ball SL, Cameron DA, Halfter W. Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy. Mol Vis 2010; 16:1415-28. [PMID: 20680099].
31. Campello L, Esteve-Rudd J, Bru-Martínez R, Herrero MT, Fernández-Villalba E, Cuenca N, Martín-Nieto J. Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of parkinsonian, MPTP-treated monkeys. PLoS One 2013; 8:e74439 [PMID: 24040246].
32. Esteve-Rudd J, Fernández-Sánchez L, Lax P, De Juan E, Martín-Nieto J, Cuenca N. Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina. Neurobiol Dis 2011; 44:102-15. [PMID: 21742033].
33. Al-Ubaidi MR, Font RL, Quiambao AB, Keener MJ, Liou GI, Overbeek PA, Baehr W. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 1992; 119:1681-7. [PMID: 1334963].
34. Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 2004; 45:764-8. [PMID: 14985288].
35. Kanan Y, Moiseyev G, Agarwal N, Ma J-X, Al-Ubaidi MR. Light induces programmed cell death by activating multiple independent proteases in a cone photoreceptor cell line. Invest Ophthalmol Vis Sci 2007; 48:40-51. [PMID: 17197514].
36. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N. α-Synuclein gene expression profile in the retina of vertebrates. Mol Vis 2007; 13:949-61. [PMID: 17653035].
37. Esteve-Rudd J, Campello L, Herrero M-T, Cuenca N, Martín-Nieto J. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res 2010; 1352:70-82. [PMID: 20638372].
38. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3-new capabilities and interfaces. Nucleic Acids Res 2012; 40:e115 [PMID: 22730293].
39. Bolte S, Cordelières FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224:213-32. [PMID: 17210054].
40. Prados B, Peña A, Cotarelo RP, Valero MC, Cruces J. Expression of the murine Pomt1 gene in both the developing brain and adult muscle tissues and its relationship with clinical aspects of Walker-Warburg syndrome. Am J Pathol 2007; 170:1659-68. [PMID: 17456771].
41. Raducu M, Cotarelo RP, Simón R, Camacho A, Rubio-Fernández M, Hernández-Laín A, Cruces J. Clinical features and molecular characterization of a patient with muscle-eye-brain disease: a novel mutation in the POMGNT1 gene. J Child Neurol 2014; 29:289-94. [PMID: 24282183].
42. Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, Van Beusekom E, Van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki A-E, Cruces J, Voit T, Walsh CA, Van Bokhoven H, Brunner HG. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002; 71:1033-43. [PMID: 12369018].
43. Van Reeuwijk J, Janssen M, Van den Elzen C, Beltran-Valero de Bernabé D, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F, Huynen MA, Verrips A, Walsh CA, Barth PG, Brunner HG, Van Bokhoven H. POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005; 42:907-12. [PMID: 15894594].
44. Voglmeir J, Kaloo S, Laurent N, Meloni MM, Bohlmann L, Wilson IBH, Flitsch SL. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease. Biochem J 2011; 436:447-55. [PMID: 21361872].
45. Michele DE, Barresi R, Kanagawa M, Saito F, Kelley RI, Somerk H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002; 418:417-22. [PMID: 12140558].
46. Fahnehjelm KT, Ygge J, Engman M-L, Mosskin M, Santavuori P, Malm G. A child with Muscle-Eye-Brain disease. Ophthalmological and neurological characteristics. Acta Ophthalmol Scand 2001; 79:72-5. [PMID: 11167293].
47. Demir E, Gucuyener K, Akturk A, Talim B, Konus O, Del Bo R, Ghezzi S, Comi GP. An unusual presentation of Muscle-Eye-Brain disease: Severe eye abnormalities with mild muscle and brain involvement. Neuromuscul Disord 2009; 19:692-5. [PMID: 19679478].
48. Cormand B, Pihko H, Bayés M, Valanne L, Santavuori P, Talim B, Gershoni-Baruch R, Ahmad A, van Bokhoven H, Brunner HG, Voit T, Topaloglu H, Dobyns WB, Lehesjoki AE. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 2001; 56:1059-69. [PMID: 11320179].
49. Santavuori P, Somer H, Sainio K, Rapola J, Kruus S, Nikitin T, Ketonen L, Leisti J. Muscle-eye-brain disease (MEB). Brain Dev 1989; 11:147-53. [PMID: 2751061].
50. Takahashi H, Kanesaki H, Igarashi T, Kameya S, Yamaki K, Mizota A, Kudo A, Miyagoe-Suzuki Y, Takeda S, Takahashi H. Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice. Mol Cell Neurosci 2011; 47:119-30. [PMID: 21447391].
51. Hu H, Yang Y, Eade A, Xiong Y, Qi Y. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease. J Comp Neurol 2007; 501:168-83. [PMID: 17206611].
52. Saredi S, Ardissone A, Ruggieri A, Mottarelli E, Farina L, Rinaldi R, Silvestri E, Gandioli C, D’Arrigo S, Salerno F, Morandi L, Grammatico P, Pantaleoni C, Moroni I, Mora M. Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease. J Neurol Sci 2012; 318:45-50. [PMID: 22554691].
53. Young RW. Visual cells and the concept of renewal. Invest Ophthalmol Vis Sci 1976; 15:700-25. [PMID: 986765].
54. Moukhles H, Roque R, Carbonetto S. α-Dystroglycan isoforms are differentially distributed in adult rat retina. J Comp Neurol 2000; 420:182-94. [PMID: 10753306].
55. Ackroyd MR, Skordis L, Kaluarachchi M, Godwin J, Prior S, Fidanboylu M, Piercy RJ, Muntoni F, Brown SC. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009; 132:439-51. [PMID: 19155270].
56. Dalloz C, Claudepierre T, Rodius F, Mornet D, Sahel J, Rendon A. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx3Cv mutation. Mol Cell Neurosci 2001; 17:908-20. [PMID: 11358487].
57. Hu H, Li J, Zhang Z, Yu M. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression. Neurosci Lett 2011; 489:10-5. [PMID: 21129441].
58. Kanagawa M, Omori Y, Sato S, Kobayashi K, Miyagoe-Suzuki Y, Takeda S, Endo T, Furukawa T, Toda T. Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localization. J Biol Chem 2010; 285:31208-16. [PMID: 20682766].
59. Omori Y, Araki F, Chaya T, Kajimura N, Irie S, Terada K, Muranishi Y, Tsujii T, Ueno S, Koyasu T, Tamaki Y, Kondo M, Amano S, Furukawa T. Presynaptic dystroglycan-pikachurin complex regulates the proper synaptic connection between retinal photoreceptor and bipolar cells. J Neurosci 2012; 32:6126-37. [PMID: 22553019].
60. Yamamoto T, Kato Y, Shibata N, Sawada T, Osawa M, Kobayashi M. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation. Int J Exp Pathol 2008; 89:332-41. [PMID: 18808525].
61. Oppizzi ML, Akhavan A, Singh M, Fata JE, Muschler JL. Nuclear translocation of β-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins. Traffic 2008; 9:2063-72. [PMID: 18764929].
62. Mitchell A, Mathew G, Jiang T, Hamdy FC, Cross SS, Eaton C, Winder SJ. Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer. Prostate 2013; 73:398-408. [PMID: 22996647].
63. Mathew G, Mitchell A, Down JM, Jacobs LA, Hamdy FC, Eaton C, Rosario DJ, Cross SS, Winder SJ. Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer. Sci Rep 2013; 3:2792 [PMID: 24077328].
64. Martínez-Vieyra IA, Vásquez-Limeta A, González-Ramírez R, Morales-Lázaro SL, Mondragón M, Mondragón R, Ortega A, Winder SJ, Cisneros B. A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts. Biochim Biophys Acta 2013; 1833:698-711. [PMID: 23220011].
65. Villarreal-Silva M, Suárez-Sánchez R, Rodríguez-Muñoz R, Mornet D, Cisneros B. Dystrophin Dp71 is critical for stability of the DAPs in the nucleus of PC12 cells. Neurochem Res 2010; 35:366-73. [PMID: 19784870].
66. Lara-Chacón B, Bermúdez de León M, Leocadio D, Gómez P, Fuentes-Mera L, Martínez-Vieyra I, Ortega A, Jans DA, Cisneros B. Characterization of an importin α/β-recognized nuclear localization signal in β-dystroglycan. J Cell Biochem 2010; 110:706-17. [PMID: 20512930].
67. González-Ramírez R, Morales-Lázaro SL, Tapia-Ramírez V, Mornet D, Cisneros B. Nuclear and nuclear envelope localization of dystrophin Dp71 and dystrophin-associated proteins (DAPs) in the C2C12 muscle cells: DAPs nuclear localization is modulated during myogenesis. J Cell Biochem 2008; 105:735-45. [PMID: 18680104].
68. Marquez FG, Cisneros B, Garcia F, Ceja V, Velázquez F, Depardón F, Cervantes L, Rendón A, Mornet D, Rosas-Vargas H, Mustre M, Montañez C. Differential expression and subcellular distribution of dystrophin Dp71 isoforms during differentiation process. Neuroscience 2003; 118:957-66. [PMID: 12732241].
69. Fuentes-Mera L, Rodríguez-Muñoz R, González-Ramírez R, García-Sierra F, González E, Mornet D, Cisneros B. Characterization of a novel Dp71 dystrophin-associated protein complex (DAPC) present in the nucleus of HeLa cells: Members of the nuclear DAPC associate with the nuclear matrix. Exp Cell Res 2006; 312:3023-35. [PMID: 16824516].
70. Parberry-Clark C, Bury JP, Cross SS, Winder SJ. Loss of dystroglycan function in oesophageal cancer. Histopathology 2011; 59:180-7. [PMID: 21884196].
71. Shen JG, Xu CY, Li X, Dong MJ, Jiang ZN, Wang J, Wang LB. Dystroglycan is associated with tumor progression and patient survival in gastric cancer. Pathol Oncol Res 2012; 18:79-84. [PMID: 21695587].
72. Zhang X, Dong X-H, Ma Y, Li L-F, Wu H, Zhou M, Gu Y-H, Li G-Z, Wang D-S, Zhang X-F, Mou J, Qi J-P. Reduction of α-dystroglycan expression is correlated with poor prognosis in glioma. Tumour Biol 2014; 35:11621-9. [PMID: 25139094].
73. Esser AK, Miller MR, Huang Q, Meier MM, Beltran-Valero de Bernabé D, Stipp CS, Campbell KP, Lynch CF, Smith BJ, Cohen MB, Henry MD. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. J Biol Chem 2013; 288:2132-42. [PMID: 23223448].
74. Zhang HZ, Xia XY, Zhu F, Shen H, Song K, Shang ZJ. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis. J Oral Maxillofac Surg 2014; 72:1106-18. [PMID: 24629698].
75. Huang Q, Miller MR, Schappet J, Henry MD. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer. Cancer Biol Ther 2015; 16:125-36. [PMID: 25455932].
76. Miller MR, Ma D, Schappet J, Breheny P, Mott SL, Bannick N, Askeland E, Brown J, Henry MD. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. Mol Cancer 2015; 14:141 [PMID: 26220087].
77. Sgambato A, Camerini A, Genovese G, De Luca F, Viacava P, Migaldi M, Boninsegna A, Cecchi M, Sepich CA, Rossi G, Arena V, Cittadini A, Amoroso D. Loss of nuclear p27kip1 and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Sci 2010; 101:2080-6. [PMID: 20626751].
78. Shimojo H, Kobayashi M, Kamigaito T, Shimojo Y, Fukuda M, Nakayama J. Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer. Prostate 2011; 71:1151-7. [PMID: 21656825].
79. Lan J, Guo P, Lin Y, Mao Q, Guo L, Ge J, Li X, Jiang J, Lin X, Qiu Y. Role of glycosyltransferase PomGnT1 in glioblastoma progression. Neuro-oncol 2015; 17:211-22. [PMID: 25085363].
80. Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, Fukuda MN, Fukuda M. Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci USA 2009; 106:12109-14. [PMID: 19587235].
81. Vester-Christensen MB, Halim A, Joshi HJ, Steentoft C, Bennett EP, Levery SB, Vakhrushev SY, Clausen H. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci USA 2013; 110:21018-23. [PMID: 24101494].
82. Dwyer CA, Katoh T, Tiemeyer M, Matthews RT. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain. J Biol Chem 2015; 290:10256-73. [PMID: 25737452].